UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Paraoxonase and atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2001-04, Vol.21 (4), p.473-480

2001

Volltextzugriff (PDF)

Impact of migration on coronary heart disease risk factors: Comparison of Gujaratis in Britain and their contemporaries in villages of origin in India

Atherosclerosis, 2006-04, Vol.185 (2), p.297-306

2006

Volltextzugriff (PDF)

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

British heart journal, 2001-05, Vol.85 (5), p.544-548

2001

Volltextzugriff (PDF)

The paraoxonase‐2‐310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus

Journal of internal medicine, 2005-10, Vol.258 (4), p.363-368

2005

Volltextzugriff (PDF)

Serum paraoxonase after myocardial infarction

Arteriosclerosis, thrombosis, and vascular biology, 1999-02, Vol.19 (2), p.330-335

1999

Volltextzugriff (PDF)

Hydrolysis of platelet-activating factor by human serum paraoxonase

Biochemical journal, 2001-02, Vol.354 (Pt 1), p.1-7

2001

Volltextzugriff (PDF)

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

Atherosclerosis, 1998-08, Vol.139 (2), p.341-349

1998

Volltextzugriff (PDF)

HDL, its enzymes and its potential to influence lipid peroxidation

Atherosclerosis, 1995-06, Vol.115 (2), p.243-253

1995

Volltextzugriff (PDF)

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

Biochemical journal, 1993-09, Vol.294 (3), p.829-834

1993

Volltextzugriff (PDF)

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

British journal of pharmacology, 1997-09, Vol.122 (2), p.265-268

1997

Volltextzugriff (PDF)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Atherosclerosis, 2003-04, Vol.167 (2), p.243-255

2003

Volltextzugriff (PDF)

Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia

BMJ. British medical journal (International ed.), 2000-12, Vol.321 (7275), p.1497

International edition, 2000

Volltextzugriff (PDF)

Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India

The Lancet (British edition), 1995-02, Vol.345 (8947), p.405-409

1995

Volltextzugriff (PDF)

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

Atherosclerosis, 1998-05, Vol.138 (1), p.217-225

1998

Volltextzugriff (PDF)

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

Atherosclerosis, 1993-12, Vol.104 (1), p.129-135

1993

Volltextzugriff (PDF)

Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy

Clinical science (1979), 2000-03, Vol.98 (3), p.355

2000

Volltextzugriff (PDF)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes

Diabetic medicine, 2002-03, Vol.19 (3), p.201-211

2002

Volltextzugriff (PDF)

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 1997-07, Vol.17 (7), p.1233-1238

1997

Volltextzugriff (PDF)

Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins

Arteriosclerosis, thrombosis, and vascular biology, 1995-11, Vol.15 (11), p.1812-1818

1995

Volltextzugriff (PDF)

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

The Lancet (British edition), 1997-03, Vol.349 (9055), p.851-852

1997

Volltextzugriff (PDF)

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

FEBS letters, 1991-07, Vol.286 (1-2), p.152-154

1991

Volltextzugriff (PDF)

The hunt for nutritional and pharmacological modulators of paraoxonase

Arteriosclerosis, thrombosis, and vascular biology, 2002-08, Vol.22 (8), p.1248-1250

2002

Volltextzugriff (PDF)

Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

European journal of clinical investigation, 2000-01, Vol.30 (1), p.4-10

2000

Volltextzugriff (PDF)

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

Arteriosclerosis, thrombosis, and vascular biology, 2001-09, Vol.21 (9), p.1451-1457

2001

Volltextzugriff (PDF)

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study

European journal of clinical investigation, 2000-11, Vol.30 (11), p.947-956

2000

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(200)
Buchkapitel
(20)

Sprache

Englisch
(220)
Japanisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Paraoxonase and atherosclerosis

Impact of migration on coronary heart disease risk factors: Comparison of Gujaratis in Britain and their contemporaries in villages of origin in India

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

The paraoxonase‐2‐310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus

Serum paraoxonase after myocardial infarction

Hydrolysis of platelet-activating factor by human serum paraoxonase

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

HDL, its enzymes and its potential to influence lipid peroxidation

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia

Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

The hunt for nutritional and pharmacological modulators of paraoxonase

Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study

Suchergebnisse filtern